Supplementary Figure S1 from Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non–Small Cell Lung Cancer
Abstract
Supplementary Figure 1. Study design and MRD sampling scheme of the NADIM II trial. Patient numbers shown for each treatment arm indicate the number of patients for whom MRD analysis was performed.
Fields of Study & Subjects
Lung Cancer Diagnosis and Treatment
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Publication details
- Publication date
- 17 February 2026
- Language
- EN